
US launches clinical trial to test antibody treatment for Long Covid
Daijiworld Media Network - Washington Washington, May 3: In a major step toward combating Long Covid, a team of US scientists has launched a clinical trial to evaluate the effectiveness of a long-acting monoclonal antibody, sipavibart, in treating the …